Vorgun-GM 1 is prescribed for patients with Type 2 Diabetes whose blood sugar is not adequately controlled by single or dual therapies.
-
Glimepiride: A sulfonylurea that stimulates the pancreas to release more insulin.
-
Voglibose: An alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestine, thereby preventing sharp blood sugar rises after meals.
-
Metformin (ER): Reduces glucose production in the liver and improves insulin sensitivity. The Extended Release (ER) technology ensures steady medication delivery throughout the day with minimal stomach irritation.
This synergistic “Triple Action” formula is highly effective in managing complex diabetes cases and reducing the risk of cardiovascular and renal complications associated with high blood sugar.
Key Benefits
-
Superior Glucose Control: Targets blood sugar through three distinct mechanisms.
-
Post-Meal Spike Protection: Voglibose specifically manages sugar levels after eating.
-
24-Hour Coverage: Metformin ER provides stable, long-lasting glycemic control.
-
HbA1c Reduction: Helps reach target sugar levels more efficiently.
-
Trusted Quality: High pharmaceutical standards from DH.
Directions for Use
-
Take this medicine exactly as prescribed by your doctor.
-
Usually taken just before or with a main meal (usually breakfast).
-
Swallow the tablet whole with water.
-
Do not crush or chew the tablet, as it may interfere with the Extended Release (ER) properties.
Safety & Precautions
-
Rx Only: A valid medical prescription is mandatory.
-
Hypoglycemia Risk: This combination can cause low blood sugar. Always keep a source of sugar (like glucose tablets or juice) handy.
-
Inform your doctor if you have kidney or liver issues, or intestinal disorders.
-
Regular monitoring of blood glucose levels is recommended.
-
Avoid alcohol as it can increase the risk of side effects like lactic acidosis.
Storage
-
Store in a cool, dry place.
-
Protect from direct sunlight and moisture.
-
Keep out of reach of children.
